Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00912236 · ClinicalTrials.gov registry record
Evaluation of High-Density Lipoprotein in Obesity Study
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 77
- Enrollment target
NCT00912236: Clinical Trial study, sponsored by The Cleveland Clinic.
NCT00912236 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00912236 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 77 participants
- Enrollment target
Study Summary
Obesity is associated with an impaired functioning HDL (good cholesterol) resulting in an acceleration in the development of atherosclerosis. This study will evaluate HDL functionality in patients with BMI (Body Mass Index) 20 - 25 and BMI \>30
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-03 |
Why NCT00912236 stopped before completion
NCT00912236 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00912236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00912236 about?
NCT00912236 is a clinical study titled "Evaluation of High-Density Lipoprotein in Obesity Study". Obesity is associated with an impaired functioning HDL (good cholesterol) resulting in an acceleration in the development of atherosclerosis. This study will evaluate HDL functionality in patients with BMI (Body Mass Index) 20 - 25 and BMI \>30
What is the current status of trial NCT00912236?
This trial is currently terminated. The enrollment target is 77 participants. The study started on 2009-06. Estimated completion is 2012-03.
Who is sponsoring clinical trial NCT00912236?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia